Holen Sie sich die Stockscreener-App
48.33
0.77%
0.37
Handel nachbörslich:
48.37
0.04
+0.08%
Schlusskurs vom Vortag:
$47.96
Offen:
$48.59
24-Stunden-Volumen:
19.17M
Relative Volume:
0.47
Marktkapitalisierung:
$10.52B
Einnahmen:
$1.78B
Nettoeinkommen (Verlust:
$164.40M
KGV:
70.04
EPS:
0.69
Netto-Cashflow:
$236.51M
1W Leistung:
-5.48%
1M Leistung:
+0.92%
6M Leistung:
-18.33%
1J Leistung:
+202.44%
1-Tages-Spanne:
$46.76
$48.65
1-Wochen-Bereich:
$46.76
$53.53
52-Wochen-Spanne:
$13.47
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Firmenname
Hims Hers Health Inc
Sektor
Telefon
415-851-0195
Adresse
2269 CHESTNUT ST, SAN FRANCISCO
Vergleichen Sie HIMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
48.33 | 11.30B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
155.41 | 363.02B | 84.28B | 15.97B | 14.04B | 6.51 |
|
UL
Unilever Plc Adr
|
62.44 | 149.32B | 65.76B | 6.16B | 0 | 2.4843 |
|
CL
Colgate Palmolive Co
|
86.34 | 68.25B | 20.00B | 2.91B | 3.37B | 3.56 |
|
KMB
Kimberly Clark Corp
|
134.81 | 44.51B | 18.88B | 2.43B | 2.10B | 7.26 |
|
KVUE
Kenvue Inc
|
21.71 | 40.72B | 15.30B | 1.06B | 1.45B | 0.55 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-23 | Herabstufung | Needham | Buy → Hold |
| 2025-06-04 | Bestätigt | Needham | Buy |
| 2025-04-29 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-02-18 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-01-10 | Herabstufung | Citigroup | Neutral → Sell |
| 2025-01-07 | Eingeleitet | BTIG Research | Buy |
| 2024-12-17 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-11-14 | Herabstufung | BofA Securities | Buy → Underperform |
| 2024-08-22 | Eingeleitet | Needham | Buy |
| 2024-08-09 | Herabstufung | Imperial Capital | Outperform → In-line |
| 2024-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-04-16 | Herabstufung | Jefferies | Buy → Hold |
| 2024-04-10 | Eingeleitet | Canaccord Genuity | Buy |
| 2024-02-28 | Hochstufung | Imperial Capital | In-line → Outperform |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2023-12-07 | Eingeleitet | Imperial Capital | In-line |
| 2023-07-28 | Eingeleitet | TD Cowen | Outperform |
| 2023-04-11 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-02-09 | Hochstufung | Jefferies | Hold → Buy |
| 2022-11-08 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-11-08 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-10-17 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-07-15 | Eingeleitet | SVB Leerink | Underperform |
| 2022-04-14 | Eingeleitet | Guggenheim | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-10 | Eingeleitet | Deutsche Bank | Hold |
| 2021-12-02 | Eingeleitet | Jefferies | Hold |
| 2021-11-11 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-07-06 | Eingeleitet | BofA Securities | Neutral |
| 2021-05-20 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2021-04-21 | Eingeleitet | Truist | Hold |
| 2021-03-09 | Eingeleitet | Credit Suisse | Neutral |
| 2021-03-02 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-02-17 | Eingeleitet | Citigroup | Neutral |
| 2021-02-12 | Eingeleitet | Piper Sandler | Neutral |
| 2021-02-08 | Eingeleitet | Tigress Financial | Buy |
Alle ansehen
Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten
The Gross Law Firm Announces the Filing of a Securities - GlobeNewswire
Hedge Fund and Insider Trading News: George Soros, Dan Loeb, Lee Ainslie, Warren Buffett, Millennium Management, Discovery Capital Management, Sculptor Capital, Warner Bros Discovery Inc (WBD), Hims & Hers Health Inc (HIMS), and More - Insider Monkey
Hims & Hers (HIMS) Falls as Key Executives Dispose Shares - Insider Monkey
Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit? - TradingView
HIMS 2-WEEK DEADLINE ALERT: HIMS Shares Decline Amid Lower - GlobeNewswire
SueWallSt Podcast Explains Class Action Against Hims & Hers Health, Inc. (HIMS) - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesHIMS - FinancialContent
The Top 5 Analyst Questions From Hims & Hers Health’s Q2 Earnings Call - Yahoo Finance
Hims & Hers Health (NYSE:HIMS) Trading Down 4.1% Following Insider Selling - Defense World
Levi & Korsinsky Urges Hims & Hers Health, Inc. (HIMS) Shareholders to Act Before Lead Plaintiff Deadline August 25, 2025 - ACCESS Newswire
HIMS Q2 Deep Dive: International Expansion and Product Shifts Define Next Growth Phase - uk.finance.yahoo.com
HIMS & HERS HEALTH SHAREHOLDER ALERT BY FORMER LOUISIANA - GlobeNewswire
Hims CEO Reports $33 Million Sale in Largest Insider Trade - Bloomberg.com
Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today - Yahoo Finance
Hims & Hers CEO sells $33 million in stock after a massive rally - MarketWatch
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - Morningstar
Hims & Hers Remains Outside Novo Nordisk's Growing Legal Storm For Now - inkl
DEADLINE ALERT for RDDT, HIMS, IRBT, and CNC: The Law - GlobeNewswire
Hims & Hers Drives the Consumer-Centric Transformation in Digital Care - Yahoo Finance
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors - GlobeNewswire
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
Hims & Hers Health CEO discloses sale of over $33M worth of company stock - MSN
Hims & Hers Health stock down on CEO insider sale (HIMS:NYSE) - Seeking Alpha
HIMS Deadline Approaching on August 25, 2025: Kessler Topaz Meltzer & Check, LLP Reminds Hims & Hers Health, Inc. (HIMS) Investors of Class Action Lawsuit Deadline | FinancialContent - FinancialContent
Lost Money on Hims & Hers Health, Inc. (HIMS)? Urged to Join Class Action Before August 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
HIMS ALERT: Levi & Korsinsky Files Securities Fraud Class Action Against Hims & Hers Health, Inc. – August 25, 2025 Deadline - ACCESS Newswire
HIMS LAWSUIT ALERT: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
HIMS LAWSUIT ALERT: Levi & Korsinsky Notifies Hims & Hers - GlobeNewswire
Did You Lose Money on Hims & Hers Health, Inc. (HIMS)? Levi & Korsinsky Urges Investors to Act Before August 25, 2025 - ACCESS Newswire
Why is Novo Nordisk excluding Hims & Hers in its lawsuits over Wegovy copies? - Fast Company
Novo ramps up lawsuits over Wegovy copiesbut not for Hims & Hers - Yahoo Finance
Is Most-Watched Stock Hims & Hers Health, Inc. (HIMS) Worth Betting on Now? - Yahoo Finance
Lost Money on Hims & Hers Health, Inc.(HIMS)? Join Class Action Suit Seeking RecoveryContact The Gross Law Firm - Morningstar
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
As Novo Nordisk ramps up lawsuits over Wegovy copies, investors ask where is Hims? - Yahoo Finance
Hims & Hers Shares Plunge. Is This a Buying Opportunity or Should Investors Run for the Hills? - The Globe and Mail
Healthcare Stocks To Research – August 8th - Defense World
Shareholders of Hims & Hers Health, Inc. (HIMS): Protect Your Rights Before August 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
Why Hims & Hers Stock Sank This Week - Mitrade
Where Will Hims & Hers Be in 5 Years? - The Globe and Mail
Best Healthcare Stocks To Add to Your Watchlist – August 7th - Defense World
Best Medical Stocks To Watch Now – August 7th - Defense World
Top Executive Sells Massive Stake in Hims & Hers Health! - TipRanks
HIMS Deadline: HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit - The Malaysian Reserve
Class Action Filed Against Hims & Hers Health, Inc. (HIMS) Over Securities ViolationsContact Levi & Korsinsky Today - ACCESS Newswire
Class Action Lawsuit Filed: Hims & Hers Health, Inc. (HIMS)Join by August 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
HIMS and the Legal Reckoning in Telehealth: Navigating the Risks of Rapid Growth in a Regulated Sector - AInvest
HIMS FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, - GlobeNewswire
DEADLINE ALERT for HIMS, IRBT, CNC, BHVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - Morningstar
Hims Stock Gets Booted Off IBD 50 While Other Volatile Names Hang On - Investor's Business Daily
HIMS Shares Decline Amid Lower Revenue Per Order For GLP-1 - GlobeNewswire
Finanzdaten der Hims Hers Health Inc-Aktie (HIMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.28%
0.87%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):